下一代聚合mRNA纳米载体:从化学工程到器官选择性基因传递
Wang Chen1, Dandan Zhu1, Meiwan Chen2
1State Key Laboratory of Natural Medicines, Joint International Research Laboratory of Target Discovery and New Drug Innovation (Ministry of Education), Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing, China.
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
|October 29, 2025
概括
聚合物载体为信使RNA (mRNA) 疗法提供先进的解决方案,克服稳定性和传递挑战. 这些材料增强了精密医学中的mRNA疗法应用.
科学领域:
- 生物技术是生物技术.
- 纳米技术 纳米技术
- 聚合物科学 聚合物科学
背景情况:
- 使者RNA (mRNA) 疗法在疫苗和癌症治疗等多种应用中表现有前途.
- 关键的挑战包括mRNA稳定性不佳,免疫性和低效的向传递.
- 聚合物载体正在成为解决这些局限性的有希望的战略.
研究的目的:
- 审查mRNA疗法的生物医学应用.
- 为突出聚合载体在mRNA传递方面的进步.
- 讨论非肝脏向的mRNA输送策略和未来的挑战.
主要方法:
- 关于mRNA疗法和聚合物输送系统的最新文献的审查.
- 对聚合物载体的化学结构多样性和合理设计原则的分析.
- 非肝脏向性交付策略和相关挑战的总结.
主要成果:
- 聚合物载体在mRNA稳定性,免疫性缓解和肝外输送方面比脂质纳米颗粒 (LNP) 有优势.
- 多样化的聚合物结构使得可调节的特性可用于优化mRNA传递.
- 在开发使用这些运营商的非肝脏向交付方法方面取得了进展.
结论:
- 聚合物载体对于克服mRNA治疗中的翻译障碍至关重要.
- 理性的设计和先进的合成是释放mRNA传递系统的全部潜力的关键.
- 为了在精准医学中得到广泛应用,需要进一步开发.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...